Funding
Funder: ABBOTT LABORATORIES S.A.
7 funding - 598,039€
2023
2021
2019
-
Follow Up Availapreg Study
euro 39,938.00
2017
2016
-
Prognostic Relevance of Clinical Pharmacological, And Structural Parameters In The Course of Patiens Included In a Registry of Acute Coronary Syndrome
euro 50,000.00
-
Analyses of The Major Facilitator Superfamily Domain Containing 2a Protein (Mfsd2a) In Placentas From The Nigo-Health Study
euro 11,313.00
2009
-
Investigación en el Área Cardiovascular
euro 150,000.00